Maternal Serum Placental Growth Factor, Soluble Fms-Like Tyrosine Kinase-1, and Soluble Endoglin in Twin Gestations and the Risk of Preeclampsia-A Systematic Review

被引:10
|
作者
Kosinska-Kaczynska, Katarzyna [1 ]
Zgliczynska, Magdalena [1 ,2 ]
Kozlowski, Szymon [3 ]
Wicherek, Lukasz [1 ]
机构
[1] Ctr Postgrad Med Educ, Dept Obstet & Gynecol 2, PL-01809 Warsaw, Poland
[2] Med Univ Warsaw, Lab Ctr Preclin Res, Chair & Dept Expt & Clin Physiol, PL-02106 Warsaw, Poland
[3] Med Univ Warsaw, Univ Ctr Woman & Newborn Hlth, PL-02015 Warsaw, Poland
关键词
placental growth factor; serum soluble fms-like tyrosine kinase-1; endoglin; preeclampsia; prediction; twin pregnancy; SFLT-1/PLGF RATIO; HYPERTENSIVE DISORDERS; ANGIOGENIC FACTORS; PREDICTIVE-VALUE; PREGNANCIES; SINGLETON; OUTCOMES; WOMEN; 1ST; COMPLICATIONS;
D O I
10.3390/jcm9010183
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Multiple gestation is one of the key risk factors for the occurrence of preeclampsia (PE). Soluble fms-like tyrosine kinase-1, placental growth factor, and soluble endoglin are molecules involved in the process of angiogenesis with a proven role in the pathogenesis of PE. The aim of the review was to summarize available data on maternal serum levels of the above-mentioned factors and their usefulness in predicting PE in twin pregnancies. Only original research articles written in English were considered eligible. Reviews, chapters, case studies, conference papers, experts' opinions, editorials, and letters were excluded from the analysis. No publication date limitations were imposed. The systematic literature search using PubMed/MEDLINE, Scopus, Embase, and Cochrane Library databases identified 338 articles, 10 of which were included in the final qualitative analyses. The included studies showed significant differences in maternal serum levels of the discussed factors between women with twin pregnancies with PE and those who did not develop PE, and their promising performance in predicting PE, alone or in combination with other factors. The identification of the most effective algorithms, their prompt introduction to the clinical practice, and further assessment of the real-life performance should become a priority.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Predictive Accuracy of Soluble FMS-Like Tyrosine Kinase-1/Placental Growth Factor Ratio for Preeclampsia in Japan: A Systematic Review
    Yamazaki, Tomomi
    Cerdeira, Ana Sofia
    Agrawal, Swati
    Koh, Iemasa
    Sugimoto, Jun
    Vatish, Manu
    Kudo, Yoshiki
    HYPERTENSION RESEARCH IN PREGNANCY, 2021, 9 (01) : 1 - 7
  • [2] Maternal serum placental growth factor and soluble fms-like tyrosine kinase 1 as early predictors of preeclampsia
    Shokry, Mahmoud
    Bedaiwy, Mohamed A.
    Fathalla, Mohamed M. F.
    Alsemary, Ali
    Elwakil, Sahar
    Murphy, Aisling
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2010, 89 (01) : 143 - 146
  • [3] Circulatory and Placental Expression of Soluble Fms-like Tyrosine Kinase-1 and Placental Growth Factor in HIV-infected Preeclampsia
    Mlambo, Zinhle P. P.
    Khaliq, Olive P. P.
    Moodley, Jagidesa
    Naicker, Thajasvarie
    CURRENT HYPERTENSION REVIEWS, 2023, 19 (01) : 27 - 33
  • [4] Competing Risks Model in Screening for Preeclampsia by Serum Placental Growth Factor and Soluble fms-Like Tyrosine Kinase-1 at 30-33 Weeks' Gestation
    Lai, Jonathan
    Larroca, Santiago Garcia-Tizon
    Peeva, Gergana
    Poon, Leona C.
    Wright, David
    Nicolaides, Kypros H.
    FETAL DIAGNOSIS AND THERAPY, 2014, 35 (04) : 240 - 248
  • [5] Intrauterine growth restriction, soluble fms-like tyrosine kinase-1 to placental growth factor ratio increase and preeclampsia
    Boulanger, H.
    Drouin, D.
    Largilliere, C.
    Lefevre, G.
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2019, 48 (08) : 695 - 697
  • [6] Threshold of Soluble Fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio for the Imminent Onset of Preeclampsia
    Ohkuchi, Akihide
    Hirashima, Chikako
    Matsubara, Shigeki
    Takahashi, Kayo
    Matsuda, Yoshio
    Suzuki, Mitsuaki
    HYPERTENSION, 2011, 58 (05) : 859 - U393
  • [7] Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia
    Khalil, A.
    Maiz, N.
    Garcia-Mandujano, R.
    Penco, J. M.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2016, 47 (03) : 324 - 331
  • [8] Placental Growth Factor and Soluble, Fms-Like Tyrosine Kinase-1 in Preeclampsia: A Case-Cohort (PEARL) Study
    Fillion, Alexandre
    Guerby, Paul
    Lachance, Caroline
    Comeau, Marie-Pier
    Bussieres, Marie-Claude
    Doucet-Gingras, Felicia-Allysson
    Zerounian, Sophie
    Demers, Suzanne
    Laforest, Genevieve
    Menzies, Didier
    Bujold, Emmanuel
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2020, 42 (10) : 1235 - 1242
  • [9] Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia
    Leanos-Miranda, Alfredo
    Campos-Galicia, Inova
    Isordia-Salas, Irma
    Rivera-Leanos, Roxana
    Fernando Romero-Arauz, Juan
    Antonio Ayala-Mendez, Jose
    Ulloa-Aguirre, Alfredo
    JOURNAL OF HYPERTENSION, 2012, 30 (11) : 2173 - 2181
  • [10] Can maternal serum soluble fms-like tyrosine kinase-1 to placental growth factor levels at term anticipate adverse pregnancy outcomes?
    Corker, Sarah A.
    Cade, Thomas J.
    Brennecke, Shaun P.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2025, 51 (01)